Home | Business News | Browse by Publication | P | PR Newswire

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies.

Publication: PR Newswire
Publication Date: 15-JUL-09 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
EXTON, Pa., July 15 /PRNewswire/ -- Morphotek , Inc., a subsidiary of Eisai Corporation of North America, and Cancer Innovations, Inc. (CII), a privately held biotechnology company specializing in the development of oncology products, today announced that they have entered into an evaluation and option agreement in which Morphotek will evaluate monoclonal antibodies targeting certain tumor-associated proteins.

The agreement with CII provides Morphotek access to several of CII's monoclonal antibodies. Morphotek will evaluate one or more of the antibodies and have the right to exercise an option for a...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Internationally Recognized Instant Mobilizer From dotMobi Adds New Fea..., July 15, 2009
Allied Security Innovations Announces New Stock Symbol., July 15, 2009
Back by Popular Demand, Wonder(R) and Home Pride(R) Breads Return to S..., July 15, 2009
NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatment..., July 15, 2009
Caixanova, IBM and INSA, in Agreement to Create a New Technology Innov..., July 15, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.